10:42 AM EST - Bellus Health Inc. : said it signed a definitive agreement to purchase 100% of the capital stock of Innodia Inc. for approximately $1.3 million. With this purchase, Bellus Health will acquire all the business of Innodia including the intellectual property assets related to its diabetes and obesity projects. The company said the purchase price of $1.3 million including the purchase of outstanding debt from Investissement Quebec, will be paid by the issuance from treasury of its common shares. Bellus Health Inc.
shares T.BLU are trading up 8 cents at $1.07.
